Dimensional Assessment of Delusions in Clinical Practice

Framework for Dimensional Assessment

• The World Health Organization, through the ICD-11, explicitly recommends enriching categorical diagnoses with dimensional symptom profiles for psychotic disorders, combining the advantages of both diagnostic approaches 1, 2
• The ICD-11 guidelines suggest a stepwise diagnostic approach, including first-level categorical diagnosis for rapid communication and treatment initiation, second-level dimensional assessment to provide nuanced profiles that inform specific treatment strategies, and third-level monitoring to track treatment response over time 1, 2

Clinical Applications for Treatment Planning

• The Alzheimer's Association recommends that dimensional assessment is critical for differentiating delirium from primary psychotic symptoms in dementia-related psychosis, with delusions in delirium characterized by acute onset, fluctuating course, and transient nature 3, 4, 5, 6
• The temporal dimension (hours to days versus chronic) distinguishes delirium-related delusions from dementia-related psychosis, according to the Alzheimer's Association guidelines 4, 5
• Perceptual disturbances accompanying delusions (visual/tactile hallucinations, illusions) strongly suggest delirium over primary psychotic disorder, as noted in the Annals of Oncology 7

Practical Implementation Algorithm

• The American Psychiatric Association suggests using validated tools (CAM for delirium, DSM-5/ICD-11 criteria for primary psychosis) to establish categorical diagnosis, and obtaining collateral history to establish baseline and time course 4, 8, 7
• The Alzheimer's Association recommends assessing dimensional profile, including measuring conviction strength, quantifying behavioral impact, identifying thematic content, and assessing stability 3, 4, 5

Critical Pitfalls to Avoid

• The Alzheimer's Association advises against assuming all delusions in dementia patients represent primary psychosis, as delirium with delusions is a medical emergency requiring immediate evaluation for infection, metabolic disturbance, or medication toxicity rather than antipsychotic treatment 3, 4, 5, 6
• The American Psychiatric Association cautions against relying solely on categorical diagnosis when selecting cognitive therapy approaches, as dimensional profiles predict which patients benefit from specific coping enhancement strategies 1, 2